<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-05-13 19:44:17Pharmacology Clinical research Food and Drug Administration Pharmaceutical industry Zicam Matrixx Initiatives Inc. v. Siracusano Zinc gluconate New Drug Application Homeopathy Medicine Pharmaceutical sciences Health |
Add to Reading List |
Microsoft Word - Lewellen_4fmt | Matrixx Initiatives, Inc. v. Siracusano)DocID: 1l9Y9 - View Document |
| Microsoft Word - Lewellen_4fmtDocID: 1a0XR - View Document |
| IFSPA 2012 Hong KongMay 2012 Statistical Reasoning in Judicial Contexts Owen Tang, Hong Yan, Tsz Leung YipDocID: 183U0 - View Document |
| Matrixx Initiatives, Inc. v. Siracusano)DocID: 11VOM - View Document |
| Erica P. John Fund, Inc. v. Halliburton Co., 131 S.Ct[removed] L.Ed.2d 24, 79 USLW 4416, Fed. Sec. L. Rep. P 96,323, 79 Fed.R.Serv.3d[removed]S.Ct[removed]Supreme Court of the United StatesDocID: YVBn - View Document |